Capsid Content
Capsid Content - Related Videos
03:24
Visualizing Heat-Treated Viral Capsids Using Transmission Electron Microscopy
0 Views •
2026
Source: Moore, M. D., et al. Alternative In Vitro Methods for the Determination of Viral Capsid Structural Integrity. J. Vis. Exp.(2017).This video demonstrates how purified viral capsids are heat-treated, prepared, and imaged using transmission electron microscopy (TEM) to reveal structural changes and heat-induced damage.
12:57
Alternative In Vitro Methods for the Determination of Viral Capsid Structural Integrity
0 Views •
Cited by 6 •
2017
Routine detection methods utilizing viral genome amplification are limited by their inability to discriminate infectious from non-infectious particles. The purpose of this article is to provide detailed protocols for alternative methods to aid in discrimination of infectious norovirus particles using aptamer binding, dynamic light scattering, and transmission electron microscopy.
07:24
In Vitro Disassembly of Influenza A Virus Capsids by Gradient Centrifugation
0 Views •
Cited by 4 •
2016
Disassembly of influenza A virus cores during virus entry into host cells is a multistep process. We describe an in vitro method to analyze the early stages of viral uncoating. In this approach, velocity gradient centrifugation is used to biochemically dissect the steps that initiate uncoating under defined conditions.
15:04
A Neuronal and Astrocyte Co-Culture Assay for High Content Analysis of Neurotoxicity
0 Views •
Cited by 46 •
2009
This article describes a novel protocol and reagent set designed for sensitive measurement of neurotoxic effects of compounds and treatments on co-cultures of neurons and astrocytes using high content analysis. Results demonstrate that high content analysis represents an exciting novel technology for neurotoxicity assessment.
13:36
Utilizing the Antigen Capsid-Incorporation Strategy for the Development of Adenovirus Serotype 5-Vectored Vaccine Approaches
0 Views •
Cited by 1 •
2015
Here, we present a protocol to generate a proof-of-principle divalent adenovirus type 5 (Ad5) vector Ad5/H5-HVR1-KWAS-HVR5-His6 by utilizing the Antigen Capsid-Incorporation strategy. This vector was demonstrated to exhibit qualitative fitness, the capability to escape Ad5-positive sera in vitro, and the antigenicity as well as immunogenicity to the incorporated antigens.
FAQs
These factors help determine whether a particle receives its intended molecular payload during capsid assembly. Packaging signals can guide payload recognition, while payload length and production conditions affect how efficiently loading occurs. Changes in any of these variables may shift production toward fully loaded, partially loaded, or empty particles, making them important targets for bioengineering optimization.
Capsid assembly does not necessarily load every particle to the same extent. Differences in packaging signals, payload length, or production conditions can produce a mixture of fully loaded, partially loaded, and empty particles. This variation affects the overall composition of a preparation and must be considered when evaluating dose, consistency, and expected delivery performance.
Loading efficiency indicates how successfully assembled particles acquire their intended payload. Higher or more consistent loading can support clearer interpretation of particle dose and composition, whereas substantial partial loading or empty-particle content can complicate performance assessments. In bioengineering studies, this relationship helps connect manufacturing conditions with the behavior of gene-delivery vectors.
Capsid content measurements can distinguish aspects of particle composition and indicate whether a preparation contains fully loaded, partially loaded, or empty particles. These results support evaluation of dose, potency, and consistency rather than relying only on the presence of assembled particles. The information is therefore useful for judging how reliably a vector preparation was produced.
During manufacturing, capsid content provides a quality-control perspective on how consistently particles are loaded with their intended payload. Researchers can use the resulting composition information to identify variation, evaluate loading efficiency, and optimize production conditions. This supports development of preparations with more interpretable particle composition and helps assess consistency across manufacturing efforts.
Payload packaging provides context for interpreting the behavior of viral or engineered delivery particles. If particles differ in loading status, measurements of particle composition, dose, or potency may not reflect equivalent payload delivery. Accounting for capsid content helps researchers relate experimental outcomes to the actual composition of the vector preparation in research and therapeutic applications.